A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
about
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
description
article
@en
im Juli 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
name
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@en
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@nl
type
label
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@en
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@nl
prefLabel
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@en
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@nl
P2093
P2860
P50
P921
P1476
A patient-derived xenograft pr ...... ronudib in metastatic melanoma
@en
P2093
Berglind O Einarsdottir
Elisa Funck-Brentano
Erik Larsson
Jonas A Nilsson
Lisa M Nilsson
Louise Carstam
Martin Scobie
Roger Olofsson Bagge
Thomas Helleday
P2860
P2888
P356
10.1038/S41419-018-0865-6
P407
P50
P577
2018-07-24T00:00:00Z
P6179
1105775303